We Can but should we? The Ethics of human enhancement and Biotechnology
Register at: http://supportahn.org/AHNClinicalEthics
The science of medicine seeks to improve and enhance the human condition, while the practice of medicine pursues health and human flourishing. The intersection of medicine, science and technology empowers us to overcome many of our mental and physical limitations in ways that could change what it means to be human.
Genetic insights and technologies help develop treatments that target causes of diseases. Technologies such as gene editing and embryo selection enable parents to curate their future children’s traits such as physical appearance, intelligence, and even immune systems. Brain-computer interfaces can help those with spinal cord injuries walk again. Such connections can also dramatically expand human cognitive abilities.
These and other biotechnologies can improve our memories, increase our stamina and strength, alter the aging process, and eliminate many disabling conditions. These biotechnologies raise ethical questions that can touch on deeply held cultural, societal, personal, and professional values that can have far-reaching implications across the patient care continuum.
This pioneering, interdisciplinary symposium explores the practical, ethical, clinical, and societal promises and perils that fuel the human enhancement debate. AHN Clinical Ethics has assembled leading voices in the field of human enhancement to probe these matters according to the themes of 1) current innovation, 2) benefits to patient health and flourishing; and 3) policy considerations concerning access to innovation. Through enlightening talks, facilitated innovative workshops, and a candid plenary discussion.
This symposium is geared to all disciplines including physicians and other clinicians, healthcare professionals, executives and administrators, graduate students and faculty, researchers, and medical, public and community policy advocates.
1. Describe many of the emerging biotechnologies and innovations designed to improve health, mitigate/reverse human suffering and limitations, and enhance human life.
2. Explain and discuss the purported patient/research subject benefits received from certain applied biotechnologies.
3. Recognize, assess, and predict the variety of ethical implications arising from many applied biotechnologies, and how they may impact clinical decisions on the frontline of care delivery.
4. Explain how the scope of enhancement technologies may impact effective/meaningful communications with patients, particularly informed consent.
5. Discuss the risks and effects of certain biotechnologies on social, cultural, and clinical biases.
Allegheny General Hospital is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
Allegheny General Hospital designates this live activity for a maximum of 6.0 AMA PRA Category 1 Credit Physicians should claim only the credit commensurate with the extent of their participation in the activity.
CE for Psychologists
Allegheny General Hospital is approved by the American Psychological Association to offer continuing education for psychologists. Allegheny Health Network maintains responsibility for the program and its content.”
CE for Social Workers
Allegheny Network is an approved provider for APA credits for Psychologists. This conference is approved for 12.0 APA credits. Social Workers may claim credits for attending educational courses and programs delivered by pre-approved providers, such as the American Psychological Association (refer to CE for Psychologists above). For verification, please refer to Continuing Education Regulations§47.36 #(6)(ix)found atwww.dos.state.pa.us/social.www.dos.state.pa.us/social.
- 5.75 AMA PRA Category 1 Credit™
- 5.75 APA
- 5.75 Attendance